Clinical response of acneiform eruptions caused by cetuximab to administration of oral tetracycline and topical ketoconazole

Journal of Dermatological Case Reports

Tosihiro Mizumoto²  Kaoru Nishi¹  Satoshi Nakamura²  Hidetoshi Takahashi¹  Hajime Iizuka¹ 

[1] Department of Dermatology, Asahikawa Medical University, Asahikawa, Japan.Department of Dermatology, Asahikawa Kousei Hospital, Asahikawa, Japan;

关键词: acne;    adverse event;    cetuximab;    colon cancer;    erlotinib;    folliculitis;    gefitinib;    ketoconazole;    panitumumab;    tetracycline;   

DOI  :  10.3315/jdcr.2014.1164

学科分类：皮肤病学

来源: Specjalisci Dermatolodz

【 摘 要 】

Cutaneous adverse events associated with the use of epidermal growth factor receptor inhibitors, such as cetuximab are relatively common. Although there are reports about possible treatments for acne or acneiform lesions induced by cetuximab, there are only few reports of prospective studies.

【 授权许可】

Unknown